WallStreetZenWallStreetZen

NASDAQ: SBFM
Sunshine Biopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sunshine Biopharma revenue was $36.34M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $9.4M, up 5.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SBFM annual revenue was $34.9M, with 44.7% growth year-over-year.

SBFM past revenue growth

How has SBFM's revenue growth performed historically?

Company
19.22%
Industry
3.27%
Market
19.5%
SBFM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SBFM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SBFM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SBFM revenue history

Current Revenue
$36.3M
Current Earnings
-$6.3M
Current Profit Margin
-17.4%

Be the first to know when SBFM announces revenue.

SBFM Revenue History By Year

SBFM Yearly RevenueSBFM RevenueSBFM ChangeSBFM Revenue Growth
2024-12-31$34.87M$10.78M+44.75%
2023-12-31$24.09M$19.75M+454.42%
2022-12-31$4.35M$4.12M+1,802.41%
2021-12-31$228.43k$157.02k+219.88%
2020-12-31$71.41k$50.29k+238.10%
2019-12-31$21.12kN/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00-$1.71k-100.00%
2015-12-31$1.71kN/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-07-31$0.00N/AN/A
2008-07-31$0.00N/AN/A
2007-07-31$0.00N/AN/A

1 of 2

Sunshine Biopharma Revenue FAQ

What was SBFM's revenue last quarter?

On Invalid Date, Sunshine Biopharma (NASDAQ: SBFM) reported Q2 2025 revenue of $9.41 million up 1.15% year over year. In the same quarter last year, Sunshine Biopharma's revenue was $9.30 million.

What was Sunshine Biopharma's revenue in 2024?

Sunshine Biopharma's annual revenue for the twelve months ending Dec 31, 2024 was $34.87 million, a 44.75% increase year over year.

How much does Sunshine Biopharma make in a day?

Based on Sunshine Biopharma annual revenue for the past five years, SBFM makes an average of $34,856.17 per day.

What was Sunshine Biopharma's annual revenue growth in the past year?

As of Q4 2025, Sunshine Biopharma's revenue has grown 19.22% year over year. This is 15.95 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 3.27%. Sunshine Biopharma's revenue in the past year totaled $36.34 million.

How much does Sunshine Biopharma make in a year?

Sunshine Biopharma's revenue by year for the past five years is:
  • Sunshine Biopharma's revenue for the twelve months ending Dec 31, 2024 was $34.87 million, a 44.75% increase year over year.
  • Sunshine Biopharma's annual revenue for Dec 31, 2023 was $24.09 million, a 454.42% increase from 2022.
  • Sunshine Biopharma's annual revenue for 2022 was $4.35 million, a 1,802.41% increase from 2021.
  • Sunshine Biopharma's annual revenue for 2021 was $228.43 thousand, a 219.88% increase from 2020.
  • Sunshine Biopharma's annual revenue for 2020 was $71.41 thousand, a 238.1% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.